|
gptkbp:instanceOf
|
medication
|
|
gptkbp:activeDuring
|
gptkb:afoxolaner
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:availableIn
|
various dosages
|
|
gptkbp:brand
|
gptkb:NexGard
|
|
gptkbp:clinicalTrials
|
conducted for safety and efficacy
|
|
gptkbp:commandStructure
|
based on weight
|
|
gptkbp:contraindication
|
hypersensitivity_to_afoxolaner
|
|
gptkbp:distribution
|
global
|
|
gptkbp:dosageForm
|
oral
|
|
gptkbp:drugInterdiction
|
true
|
|
gptkbp:evaluates
|
high against fleas
high against ticks
|
|
gptkbp:fledgingPeriod
|
none
|
|
gptkbp:formulation
|
chewable tablet
|
|
gptkbp:frequency
|
monthly
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
NexGard
|
|
gptkbp:interactsWith
|
may interact with other medications
|
|
gptkbp:lastProduced
|
2013
|
|
gptkbp:manufacturer
|
Merial
|
|
gptkbp:marketedAs
|
gptkb:NexGard_Chewables
|
|
gptkbp:offersCoursesIn
|
gptkb:Australia
gptkb:Brazil
gptkb:Canada
gptkb:France
gptkb:Germany
gptkb:India
gptkb:Japan
gptkb:Mexico
gptkb:UK
gptkb:USA
|
|
gptkbp:packaging
|
blister pack
|
|
gptkbp:patentStatus
|
patented
|
|
gptkbp:relatedPatent
|
gptkb:Frontline
Revolution
Advantix
|
|
gptkbp:safetyFeatures
|
consult veterinarian before use
|
|
gptkbp:shelfLife
|
24 months
|
|
gptkbp:sideEffect
|
vomiting
diarrhea
lethargy
loss of appetite
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:suitableFor
|
veterinarians
|
|
gptkbp:targetMarket
|
pet owners
|
|
gptkbp:targets
|
dogs
|
|
gptkbp:type
|
gptkb:afoxolaner
|
|
gptkbp:usedFor
|
tick control
flea control
|
|
gptkbp:userReviews
|
generally positive
|